Can You Trust Your Gut? Implicating a Disrupted Intestinal Microbiome in the Progression of NAFLD/NASH
Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disorders, ranging from fatty liver to a more insulin resistant, inflammatory and fibrotic state collectively termed non-alcoholic steatohepatitis (NASH). In the United States, 30%–40% of the adult population has fatty liver and 3%–12% has N...
Main Authors: | Kavita Jadhav, Taylor S. Cohen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-10-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2020.592157/full |
Similar Items
-
Gut-Pancreas-Liver Axis as a Target for Treatment of NAFLD/NASH
by: Gianluca Svegliati-Baroni, et al.
Published: (2020-08-01) -
Molecular Mechanisms and New Treatment Strategies for Non-Alcoholic Steatohepatitis (NASH)
by: Akinobu Takaki, et al.
Published: (2014-04-01) -
Insights into the Impact of Microbiota in the Treatment of NAFLD/NASH and Its Potential as a Biomarker for Prognosis and Diagnosis
by: Julio Plaza-Díaz, et al.
Published: (2021-02-01) -
The Other Side of Malnutrition in Inflammatory Bowel Disease (IBD): Non-Alcoholic Fatty Liver Disease
by: Giulia Gibiino, et al.
Published: (2021-08-01) -
Gut Microbiome and Metabolites in Patients with NAFLD and after Bariatric Surgery: A Comprehensive Review
by: Jacqueline Hoozemans, et al.
Published: (2021-05-01)